Point-of-Care Diagnostics Market is expected to be around US$ 65.80 Billion by 2028 at a CAGR of 9.6% in the given forecast period.
Factors, for example, high predominance of irresistible diseases in developing nations, rising rate of target diseases, and growing inclination for home healthcare over the globe are growing the selection of POC diagnostics items universally. Rising speculation by numerous open associations is even a driving element for the growth of POC diagnostic market.
Point-of-care (POC) diagnostics or near-patient testing is a medicinal analytic test that enables doctors and restorative staff to accurately accomplish constant, lab-quality diagnostic outcomes inside minutes instead of hours. Using versatile blood analyzers, testing at the “purpose of consideration” streamlines the diagnostic procedure and guarantees patients get the best and proficient consideration when and where it is required. Point-of-care (POC) diagnostic testing grants staff to settle on fast triage and treatment choices when diagnosing a patient’s condition or checking a treatment reaction.
The global Point-of-Care Diagnostics market is segregated on the basis of Product as Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, and Other. Based on End-User the global Point-of-Care Diagnostics market is segmented in Hospitals, Ambulatory Care, and Home.
The global Point-of-Care Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Point-of-Care Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Abaxis, Samsung Medison, Bayer, Danaher Corporation, and others are among the major players in the global Point-of-Care Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Point-of-Care Diagnostics Market has been segmented as below:
Point-of-Care Diagnostics Market, By Product
Point-of-Care Diagnostics Market, By End-User
Point-of-Care Diagnostics Market, By Region
Point-of-Care Diagnostics Market, By Company
The report covers:
Report Scope:
The global Point-of-Care Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Point-of-Care Diagnostics market share. Major industry players with significant revenue share include Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Abaxis, Samsung Medison, Bayer, Danaher Corporation, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Unit Dose Drug Delivery Systems Market
Rehabilitation Exercise Equipment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Point-of-Care Diagnostics Market, By Product
5.1 Introduction
5.2 Urinalysis Testing Kits
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cholesterol Test Strips
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Drugs-Of-Abuse Testing Kits
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Tumor/Cancer Markers
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Glucose Monitoring Kits
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Infectious Diseases Testing Kits
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Cardiometabolic Monitoring Kits
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Coagulation Monitoring Kits
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Hematology Testing Kits
5.10.1 Market Overview
5.10.2 Market Size and Forecast
5.11 Other
5.11.1 Market Overview
5.11.2 Market Size and Forecast
6. Point-of-Care Diagnostics Market, By End-User
6.1 Introduction
6.2 Hospitals
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Ambulatory Care
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Home
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Point-of-Care Diagnostics Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Point-of-Care Diagnostics, By Product
7.2.2 North America Point-of-Care Diagnostics, By End-User
7.3 Europe
7.3.1 Europe Point-of-Care Diagnostics, By Product
7.3.2 Europe Point-of-Care Diagnostics, By End-User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Point-of-Care Diagnostics, By Product
7.4.2 Asia-Pacific Point-of-Care Diagnostics, By End-User
7.5 Rest of the World
7.5.1 Rest of the World Point-of-Care Diagnostics, By Product
7.5.2 Rest of the World Point-of-Care Diagnostics, By End-User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Becton Dickinson
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Johnson & Johnson
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Nipro
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Roche Diagnostics
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Siemens Healthcare
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Abaxis
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Samsung Medison
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Bayer
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Danaher Corporation
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Point-of-Care Diagnostics Market has been segmented as below:
Point-of-Care Diagnostics Market, By Product
Point-of-Care Diagnostics Market, By End-User
Point-of-Care Diagnostics Market, By Region
Point-of-Care Diagnostics Market, By Company
